Tremelimumab | All | Licensing, EU CTD Dossiers, Formulation Suppliers | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Tremelimumab
FDF Dossiers

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

Contact Supplier

Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

Contact Supplier

Inke S.A: APIs manufacturing plant.

Contact Supplier

Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Tremelimumab

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 USDMF

1 API Suppliers
1 USDMF

DEVELOPMENTS

155 Drugs in Development

155 Drugs in Development

FINISHED DOSAGE FORMULATIONS

10 FDF Dossiers, 4 FDA Orange Book, 5 Europe, 1 Canada

10 FDF Dossiers
4 FDA Orange Book
5 Europe
1 Canada

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 34 News #PharmaBuzz

1 Data Compilation #PharmaFlow
34 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 Annual Reports

1 Annual Reports

PATENTS & EXCLUSIVITIES

1 Health Canada Patents

1 Health Canada Patents

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

10 All

01 10AstraZeneca

filter Dosage Reset all filters

10 All

01 1Concentrate For Infusion Solution

02 4Concentrate For Solution For Infusion

03 4INJECTABLE;INTRAVENOUS

04 1SOLUTION

filter Regulatory Info Reset all filters

10 All

01 2Allowed

02 1Approved

03 1Authorized

04 1Deregistered

05 1Prescription

06 4Blank

filter Brand Name Reset all filters

10 All

01 5IMJUDO

02 3Imjudo

03 1Imjudo

04 1Tremelimumab Astrazeneca

filter Country Reset all filters

10 All

01 1Canada

02 1Spain

03 2Sweden

04 2Switzerland

05 4USA

List of Suppliers

Product Main Page

01

AstraZeneca

Aus. Peptide Conference

Not Confirmed

AstraZeneca

Aus. Peptide Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : USA

TREMELIMUMAB-ACTL

Brand Name : IMJUDO

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 25MG/1.25ML(20MG/ML)

Packaging :

Approval Date :

Application Number : 761270

Regulatory Info :

Registration Country : USA

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

AstraZeneca

Aus. Peptide Conference

Not Confirmed

AstraZeneca

Aus. Peptide Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : USA

TREMELIMUMAB-ACTL

Brand Name : IMJUDO

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 300MG/15ML(20MG/ML)

Packaging :

Approval Date :

Application Number : 761270

Regulatory Info :

Registration Country : USA

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

AstraZeneca

Aus. Peptide Conference

Not Confirmed

AstraZeneca

Aus. Peptide Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : USA

TREMELIMUMAB-ACTL

Brand Name : IMJUDO

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 25MG/1.25ML(20MG/ML)

Packaging :

Approval Date :

Application Number : 761289

Regulatory Info :

Registration Country : USA

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

AstraZeneca

Aus. Peptide Conference

Not Confirmed

AstraZeneca

Aus. Peptide Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : USA

TREMELIMUMAB-ACTL

Brand Name : IMJUDO

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 300MG/15ML(20MG/ML)

Packaging :

Approval Date :

Application Number : 761289

Regulatory Info :

Registration Country : USA

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

AstraZeneca

Aus. Peptide Conference

Not Confirmed

AstraZeneca

Aus. Peptide Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Approved

Registration Country : Sweden

Tremelimumab

Brand Name : Imjudo

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 20mg/ml

Packaging :

Approval Date : 20/02/2023

Application Number : 20220307000068

Regulatory Info : Approved

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

AstraZeneca

Aus. Peptide Conference

Not Confirmed

AstraZeneca

Aus. Peptide Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Deregistered

Registration Country : Sweden

Tremelimumab

Brand Name : Tremelimumab Astrazeneca

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 20mg/ml

Packaging :

Approval Date : 20/02/2023

Application Number : 20211125000064

Regulatory Info : Deregistered

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

AstraZeneca

Aus. Peptide Conference

Not Confirmed

AstraZeneca

Aus. Peptide Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Allowed

Registration Country : Switzerland

Tremelimumab

Brand Name : Imjudo

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 25mg/1.25ml

Packaging :

Approval Date : 13/09/2023

Application Number : 68706

Regulatory Info : Allowed

Registration Country : Switzerland

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

AstraZeneca

Aus. Peptide Conference

Not Confirmed

AstraZeneca

Aus. Peptide Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Allowed

Registration Country : Switzerland

Tremelimumab

Brand Name : Imjudo

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 300mg/15ml

Packaging :

Approval Date : 13/09/2023

Application Number : 68706

Regulatory Info : Allowed

Registration Country : Switzerland

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

AstraZeneca

Aus. Peptide Conference

Not Confirmed

AstraZeneca

Aus. Peptide Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

TREMELIMUMAB

Brand Name : IMJUDO

Dosage Form : SOLUTION

Dosage Strength : 20MG/ML

Packaging :

Approval Date :

Application Number : 2541009

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

AstraZeneca

Aus. Peptide Conference

Not Confirmed

AstraZeneca

Aus. Peptide Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Authorized

Registration Country : Spain

Tremelimumab

Brand Name : Imjudo

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 20MG

Packaging :

Approval Date : 2023-03-01

Application Number : 1221713002

Regulatory Info : Authorized

Registration Country : Spain

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!